Cita APA (7a ed.)
Liu, J., Wang, X., Li, Z., Gao, S., Mao, L., Dai, J., . . . Si, L. (2024). Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: A phase Ib trial. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-024-02029-2
Cita Chicago Style (17a ed.)
Liu, Jiayong, et al. "Neoadjuvant Oncolytic Virus Orienx010 and Toripalimab in Resectable Acral Melanoma: A Phase Ib Trial." Signal Transduction and Targeted Therapy 2024. https://doi.org/10.1038/s41392-024-02029-2.
Cita MLA (9a ed.)
Liu, Jiayong, et al. "Neoadjuvant Oncolytic Virus Orienx010 and Toripalimab in Resectable Acral Melanoma: A Phase Ib Trial." Signal Transduction and Targeted Therapy, 2024, https://doi.org/10.1038/s41392-024-02029-2.
Precaución: Estas citas no son 100% exactas.